Collaborate with us
Amniotics is a biopharma company, dedicated to developing and bringing cell based Regenerative Medicine to the market for the benefit of patients suffering from rare and life-threatening diseases with high unmet need.
Our unique technology is based on collecting Mesenchymal Stem Cells (MSCs) from amniotic fluid collected at planned full-term caesarean sections, followed by a patent-protected enhancement of the MSCs into several kinds of tissue (or organ) targeted drug candidates for lung-, kidney-, skin- and neuronal diseases.
Moreover, we are also advancing induced pluripotent stem cells (iPSCs) for development of blood products.
We are actively looking to establish strategic partnerships with researchers and companies to enable and accelerate the development of our stem-cell-based therapies. See our pipeline here
GMP facility & CDMO services
- Process development for ATMPs (cell and gene therapy products) at our GMP manufacturing site in Lund, Sweden
- Working with SME companies to help launch of products
- Helping to solve operational challenges such as capacity constraints